Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (2): 372-380    DOI: 10.31083/j.ceog.2021.02.2311
Original Research Previous articles | Next articles
Low molecular weight heparin in pregnancies with persistently abnormal uterine artery Doppler, does it make a difference? A prospective proof of concept study
Eman Aly Abd El Fattah1, *()
1Department of Obstetrics and Gynecology, Alexandria University, Faculty of Medicine, Shatby Maternity Hospital, 21526 Alexandria, Egypt
Download:  PDF(519KB)  ( 97 ) Full text   ( 16 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Introduction: Trophoblastic invasion converts the uteroplacental circulation into a low resistance, high capacitance system. Defective invasion causes hypoperfusion and pregnancy complications. Early pregnancy uterine artery Doppler demonstrates low end-diastolic velocities. Its PI and RI decrease with increasing gestation. Aim of the study: Examing the effect of adding low molecular weight heparin (LMWH) to low-dose aspirin on persistent high uterine artery Doppler indices and its impact on fetal growth and pregnancy outcome. Patients and methods: After approval of Alexandria university ethics committee, pregnant cases with positive past history of placental vascular complication including; placental abruption, pre-eclampsia, small-for-gestational age (SGA) pregnancies and fetal growth restriction were recruited. All selected patients were in good general health without previous history of Diabetes Mellitus or thyroid disorders or cardiac diseases. Patients with thrombocytopenia, bleeding tendencies, multiple pregnancies, and pregnancies complicated by fetal or neonatal chromosomal or structural anomalies were excluded from the study. Eligible patients were 412, all were subjected to uterine artery Doppler measurement in the first trimester. 148 cases had high uterine artery Doppler PI, they were given low dose aspirin and were re-evaluated at 22–24 weeks gestation. 58 cases had persistently high uterine artery Doppler PI, they were allocated into 2 groups each of 29 cases; Group A LMWH with aspirin. Group B only low dose aspirin. 50 pregnants with normal uterine artery Doppler PI from the start were taken as a control group. All participants were followed up at 28–30 and 34–36 weeks. Primary outcome: Normal uterine, umbilical and cerebral artery Doppler measurements after LMWH. Secondary outcome: Prevention of pregnancy complications and neonatal complications. Results: Uterine and umbilical artery Doppler and amount of liquor significantly improved. Conclusion: LMWH influenced uterine artery and umbilical Doppler measurements and amount of liquor and reduced the risk of neonatal hypoxic ischaemic encephalopathy.
Key words:  LMWH      Uterine Doppler      Umbilical Doppler      Oligohydramnios     
Submitted:  29 September 2020      Revised:  20 January 2021      Accepted:  22 January 2021      Published:  15 April 2021     
*Corresponding Author(s):  eman0eman0eman7@Gmail.com; emanaly91171@gmail.com (Eman Aly Abd El Fattah)   

Cite this article: 

Eman Aly Abd El Fattah. Low molecular weight heparin in pregnancies with persistently abnormal uterine artery Doppler, does it make a difference? A prospective proof of concept study. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 372-380.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.02.2311     OR     https://ceog.imrpress.com/EN/Y2021/V48/I2/372

No related articles found!
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Prakash C. Deedwania. Management of Patients With Stable Angina and Type 2 Diabetes[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 105 -113 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[7] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .
[8] Dean J. Kereiakes. Coronary Small-Vessel Stenting in the Era of Drug Elution[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 34 -45 .
[9] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[10] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .